
Cytocristin 2mg Injection
Marketer
Cipla Ltd
Salt Composition
Vincristine (2mg)
Overview Cytocristin 2mg Injection
Oncaspar 2mg Injection, an anti-neoplastic agent, is indicated for various cancers including breast, non-small cell lung, pancreatic, renal, hematologic malignancies (such as multiple myeloma and lymphomas), and bone cancers. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue use only as directed by your physician. Common side effects include alopecia, peripheral paresthesia (numbness and tingling in extremities), and bowel irregularity. This medication can decrease white blood cell counts, raising infection risk, and may, in some instances, induce uric acid-associated nephropathy. Regular blood tests monitoring blood cell counts, cardiac function, hepatic function, and uric acid levels are essential. Inform your physician of all concurrent medications, as interactions may occur. Use during pregnancy or lactation is contraindicated; effective contraception is advised for both partners. Avoid direct ocular contact to prevent irritation.
Uses of Cytocristin 2mg Injection
Cancers affecting the breast, lung (non-small cell), pancreas, kidney, blood (including multiple myeloma), lymphatic system, and bone.
Major Benefits of Cytocristin 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cytocristin 2mg Injection:
- Hair loss
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Constipation
How to use Cytocristin 2mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cytocristin 2mg Injection works:
Cytocristin 2mg Injection inhibits DNA replication within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cytocristin 2mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cytocristin 2mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Cytocristin 2mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Cytocristin 2mg Injection may induce adverse reactions that could impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should receive Cytocristin 2mg Injection only with careful monitoring. A modified dosage of Cytocristin 2mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Cytocristin 2mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cytocristin 2mg Injection :
NA
Facts to Know About Cytocristin 2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Vinca-derived anticancer agents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Vinca Alkaloid Antimicrotubule Agents |
